Document Detail


Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.
MedLine Citation:
PMID:  12388659     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Isolated hepatic perfusion (IHP) with melphalan is used for patients with nonresectable metastases confined to the liver. To improve the efficacy of IHP and to reduce the toxicity to the liver, reversion (retrograde perfusion) of the bloodstream through the liver in a rat model was studied. For liver tumor induction male WAG/Rij rats were inoculated with CC531 cells, a colorectal tumor cell line. After 11 to 12 days the tumor-bearing rat livers were perfused by single-pass perfusion through either the portal (orthograde) or caval vein (retrograde) for different time periods. During perfusion melphalan (160 Schultze) was infused in the hepatic artery. Melphalan concentrations were measured by high-performance liquid chromatography. A rapid extraction of melphalan by the liver occurred in the first 5 min, reaching steady state after 10 to 20 min for both perfusion directions. The melphalan concentration of the outflow perfusate was significantly higher in the retrograde perfusion compared with the orthograde perfusion. The melphalan content of the tumor tissue was unaffected by perfusion direction at any time point. To the contrary, the melphalan uptake in liver tissue was strongly influenced: the melphalan content after 40-min retrograde perfusion was 12% of that after orthograde perfusion. The average tumor/liver concentration ratio was 6 for orthograde perfusion and 30 for retrograde perfusion. In conclusion, retrograde IHP with continuous melphalan infusion in the hepatic artery provides a high tumor uptake of melphalan with potentially reduced liver toxicity compared with orthograde IHP.
Authors:
Joost Rothbarth; Rolf W Sparidans; Jos H Beijnen; Leo J Schultze-Kool; Hein Putter; Cornelis J H van de Velde; Gerard J Mulder
Related Documents :
7125959 - The effect of repeated hemoperfusion over charcoal in the conscious rat on liver pathop...
8472619 - The inhibitory action of buformin, a biguanide on gluconeogenesis from alanine and its ...
6522239 - Contraluminal sulfate transport in the proximal tubule of the rat kidney. i. kinetics, ...
6259949 - Changing activities of galactose-metabolizing enzymes during perfusion of suckling-rat ...
3615169 - Isolated perfused rat kidney and liver combined. a new experimental model.
7766919 - Evaluation of mucosal damage of surfactants in rat jejunum and colon.
12064339 - Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extr...
206499 - Postmaturity in the rat: phosphorylase, glucose-6-phosphatase and phosphoenolpyruvate c...
9089639 - Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsai...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  303     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  2002 Nov 
Date Detail:
Created Date:  2002-10-21     Completed Date:  2002-11-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  736-40     Citation Subset:  IM    
Affiliation:
Department of Surgery, Leiden/Amsterdam Center for Drug Research, Leiden University, 2300 RA Leiden, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents, Alkylating / administration & dosage,  pharmacokinetics,  pharmacology*
Chromatography, High Pressure Liquid
Hepatic Artery
Infusions, Intravenous
Liver / metabolism*
Liver Neoplasms / metabolism*
Male
Melphalan / administration & dosage,  pharmacokinetics,  pharmacology*
Neoplasm Transplantation
Perfusion
Rats
Rats, Inbred Strains
Chemical
Reg. No./Substance:
0/Antineoplastic Agents, Alkylating; 148-82-3/Melphalan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models o...
Next Document:  Pharmacokinetics and metabolism of infused versus inhaled iloprost in isolated rabbit lungs.